Search Results - "JE. Goasguen"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia : prognostic implications by GOASGUEN, J. E, DOSSOT, J.-M, FARDEL, O, LE MEE, F, LE GALL, E, LEBLAY, R, LEPRISE, P. Y, CHAPERON, J, FAUCHET, R

    Published in Blood (01-05-1993)
    “…Immunocytochemical detection of the multidrug resistance (MDR)-associated membrane protein (P-170) was performed at time of diagnosis in a series of 36…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Impact of Topoisomerase II alpha and Spermine on the clinical outcome of children with acute lymphoblastic leukemia by Grandgirard, Nathalie, Ly-Sunnaram, Beatrice, Ferrant, Dominique, Gandemer, Virginie, Edan, Christine, Le Gall, Edouard, Moulinoux, Jacques-Phillipe, Leray, Emmanuelle, Goasguen, Jean E.

    Published in Leukemia research (01-05-2004)
    “…It has been reported in the literature that a leukemic cell may be (or become) resistant to anti-cancer treatment because many mechanisms, such as efflux…”
    Get full text
    Journal Article
  5. 5

    LRP overexpression in monocytic lineage by Sunnaram, Béatrice Ly, Gandemer, Virginie, Sebillot, Martine, Grandgirard, Nathalie, Amiot, Laurence, Leray, Emmanuelle, Goasguen, Jean E.

    Published in Leukemia research (01-08-2003)
    “…The failure to chemotherapy is a multi factorial phenomenon and lung resistance protein (LRP) overexpression has already been discussed as implicated in drug…”
    Get full text
    Journal Article
  6. 6

    Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology by Goasguen, Jean E, Zandecki, Marc, Mathiot, Claire, Scheiff, Jean-Marie, Bizet, Marie, Ly-Sunnaram, Béatrice, Grosbois, Bernard, Monconduit, Matthieu, Michaux, Jean-Louis, Facon, Thierry

    Published in Leukemia research (01-12-1999)
    “…The relationship between plasmablastic cells and outcome in multiple myeloma (MM) has been established for nearly 15 years. But the assessment of these cells…”
    Get full text
    Journal Article
  7. 7

    P-glycoprotein (P-170) and CD34 expression in adult acute myeloid leukemia (AML) by Lamy, T, Goasguen, J E, Mordelet, E, Grulois, I, Dauriac, C, Drenou, B, Chaperon, J, Fauchet, R, le Prise, P Y

    Published in Leukemia (01-11-1994)
    “…We investigated the prognosis value of CD34 and P-170 expression in blast cells of adult patients affected by de novo acute myeloid leukemia (AML). CD34…”
    Get more information
    Journal Article
  8. 8

    Erythrocyte spermine levels : a prognostic parameter in childhood common acute lymphoblastic leukemia by BERGERON, C, BANSARD, J. Y, LE MOINE, P, BOUET, F, GOASGUEN, J. E, MOULINOUX, J. P, LE GALL, E, CATROS-QUEMENER, V

    Published in Leukemia (1997)
    “…Polyamines have been implicated to play a role in cell proliferation and in cancer development. Ninety percent of the circulating spermidine (Spd) and spermine…”
    Get full text
    Journal Article
  9. 9

    Prognostic factors of myelodysplastic syndromes--a simplified 3-D scoring system by Goasguen, J E, Garand, R, Bizet, M, Bremond, J L, Gardais, J, Callat, M P, Accard, F, Chaperon, J

    Published in Leukemia research (1990)
    “…From 1 January 1982 to 31 December 1986 in five haematological centers of the west of France (Rennes, Rouen, Nantes, Tours and Angers), we have collected 503…”
    Get more information
    Journal Article
  10. 10

    Multifactorial drug-resistance phenomenon in acute leukemias: impact of P170-MDR1, LRP56 protein, glutathione-transferases and metallothionein systems on clinical outcome by Goasguen, J E, Lamy, T, Bergeron, C, Ly Sunaram, B, Mordelet, E, Gorre, G, Dossot, J M, Le Gall, E, Grosbois, B, Le Prisé, P Y, Fauchet, R

    Published in Leukemia & lymphoma (1996)
    “…The multidrug resistance phenomenon can be observed in cases which do not express the P170 protein and these cases are suspected as having activated different…”
    Get more information
    Journal Article
  11. 11

    Expression of the multidrug resistance-associated P-glycoprotein (P- 170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications [see comments] by Goasguen, JE, Dossot, JM, Fardel, O, Le Mee, F, Le Gall, E, Leblay, R, LePrise, PY, Chaperon, J, Fauchet, R

    Published in Blood (01-05-1993)
    “…Immunocytochemical detection of the multidrug resistance (MDR)- associated membrane protein (P-170) was performed at time of diagnosis in a series of 36…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Heterogeneity of acquired idiopathic sideroblastic anaemia (AISA) by Garand, R, Gardais, J, Bizet, M, Bremond, J L, Accard, F, Callat, M P, de Bouchony, E T, Goasguen, J E

    Published in Leukemia research (1992)
    “…Clinical, haematological and outcome data were studied in 84 patients with acquired idiopathic sideroblastic anaemia (AISA) from a registry of 613 consecutive…”
    Get more information
    Journal Article
  14. 14

    Prognostic implication and characterization of the blast cell population in the myelodysplastic syndrome by Goasguen, J E, Bennett, J M, Cox, C, Hambley, H, Mufti, G, Flandrin, G

    Published in Leukemia research (1991)
    “…The bone marrow smears of 18 confirmed cases of MDS were analyzed carefully for the presence of "hypergranular type III blasts", defined as more than 20 fine…”
    Get more information
    Journal Article
  15. 15

    Classifications of acute myeloid leukemia by Goasguen, J E, Bennett, J M

    Published in Clinics in laboratory medicine (01-12-1990)
    “…A detailed description of the various subtypes of the acute myeloid leukemias is provided. The importance of cytochemistry and monoclonal antibodies is…”
    Get more information
    Journal Article
  16. 16

    PLASMA CELL MORPHOLOGY IN MULTIPLE MYELOMA by JP. Mufuta, EK. Gini, NZ. Kayembe, JE. Goasguen

    Published in Rwanda Medical Journal (01-12-2014)
    “…Objective: To identify the different types of plasma cells in multiple myeloma. To evaluate the survival of patients according to plasma cell morphology…”
    Get full text
    Journal Article